Jamaica vs Kyrgyzstan: Cause of death, by non-communicable diseases, ages 0-4
Jamaica
22.8%
in 2021
Kyrgyzstan
22.4%
in 2021
Jamaica rank
118th
Kyrgyzstan rank
121st
Cause of death, by non-communicable diseases, ages 0-4 over time
- Jamaica
- Kyrgyzstan
How they compare
Jamaica currently reports 22.8% against 22.4% in Kyrgyzstan, a difference of 0.4%.
Across all 6 years both countries report, Jamaica has been ahead every year.
Jamaica ranks 118th and Kyrgyzstan ranks 121st of 185 countries.
Jamaica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jamaica | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.5% | 11.5% | 5.0% | Jamaica |
| 2010s | 23.4% | 19.5% | 4.0% | Jamaica |
| 2020s | 22.7% | 22.3% | 0.4% | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Jamaica or Kyrgyzstan?
- Jamaica, at 22.8% against 22.4% in Kyrgyzstan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Jamaica and Kyrgyzstan?
- 0.4%, with Jamaica ahead.
- How many years of comparable data are there for Jamaica and Kyrgyzstan?
- 6 years are reported by both, from 2000 to 2021.
- How do Jamaica and Kyrgyzstan rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Jamaica ranks 118th and Kyrgyzstan ranks 121st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.